Model Gateway: Management Platform for Model-Driven Drug Discovery
Pharmaceutical drug discovery demands machine learning (ML) infrastructure that goes beyond general-purpose Machine Learning Operations (MLOps): inference-time composition of multiple models for multi-parameter optimization (MPO), version management for physics-based models without serialized ML artifacts, enterprise compound library precomputation, and governance structured around scientific organizational units rather than generic access controls. No existing commercial or open-source platform simultaneously addresses this full set of requirements. This paper presents the Model Gateway, a cloud-based platform for managing machine learning and scientific computational models across drug discovery pipelines, providing centralized version control, pharma-structured governance, asynchronous execution, consensus model orchestration, automated retraining, and a unified application programming interface (API) service for heterogeneous clients including molecular design suites and Large Language Model (LLM) agents. In production at Eli Lilly, the platform governs more than 200 deployed models spanning small molecule, peptide, and antibody modalities and serves more than five downstream applications across all phases of the Design-Make-Test-Analyze cycle.
Code (0)
등록된 구현이 없습니다.
Tasks
Drug DiscoverySimilar Papers 제목 키워드 기반
Accelerating drug discovery with Artificial: a whole-lab orchestration and scheduling system for self-driving labs
Self-driving labs are transforming drug discovery by enabling automated, AI-guided experimentation, but they face challenges in orchestrating complex workflows, integrating diverse instruments and AI models, and managing…
Decision MakingDrug DiscoverySchedulingAI-driven Alternative Medicine: A Novel Approach to Drug Discovery and Repurposing
AIAltMed is a cutting-edge platform designed for drug discovery and repurposing. It utilizes Tanimoto similarity to identify structurally similar non-medicinal compounds to known medicinal ones. This preprint introduces …
Drug DiscoveryCausal Network Models of SARS-CoV-2 Expression and Aging to Identify Candidates for Drug Repurposing
Given the severity of the SARS-CoV-2 pandemic, a major challenge is to rapidly repurpose existing approved drugs for clinical interventions. While a number of data-driven and experimental approaches have been suggested i…
Drug DiscoveryPharmAgents: Building a Virtual Pharma with Large Language Model Agents
The discovery of novel small molecule drugs remains a critical scientific challenge with far-reaching implications for treating diseases and advancing human health. Traditional drug development--especially for small mole…
Drug DiscoveryLanguage ModelingLanguage ModellingLarge Language ModelBSL: A Unified and Generalizable Multitask Learning Platform for Virtual Drug Discovery from Design to Synthesis
Drug discovery is of great social significance in safeguarding human health, prolonging life, and addressing the challenges of major diseases. In recent years, artificial intelligence has demonstrated remarkable advantag…
Drug Discovery